PT-141 30mg Research Spray

PT-141 30mg Research Spray is a research-oriented peptide formulation associated with PT-141 (bremelanotide) research. PT-141 is a synthetic cyclic peptide analogue of alpha-melanocyte-stimulating hormone (α-MSH) that has been investigated for its interaction with melanocortin receptors, including MC3R and MC4R.

The product is presented strictly as a research material for qualified laboratory, analytical, educational, and scientific research applications. Research involving PT-141 has included peptide chemistry, melanocortin receptor biology, molecular signaling, pharmacological characterization, and formulation research.

The 30mg product is supplied in a liquid spray format. Researchers should consult the applicable product specifications and batch documentation for formulation details, concentration, storage requirements, and analytical information.

For Research Use Only. Not for Human Consumption.

PT-141 30mg Product Information

Product Name: PT-141 30mg Research Spray
Compound: PT-141 / Bremelanotide
Quantity: 30mg
Product Type: Research peptide formulation
Format: Liquid spray
Research Area: Melanocortin receptor research
Intended Application: Laboratory and analytical research
Documentation: Batch-specific documentation where available
Purity: Refer to the applicable Certificate of Analysis
Storage: Follow product-specific documentation
Use: Research use only

Researchers should verify the current product specifications and applicable batch documentation before incorporating the material into a laboratory workflow.

What Is PT-141?

PT-141, also known as bremelanotide, is a synthetic cyclic peptide analogue related to α-MSH. Scientific research has investigated PT-141 as an agonist of melanocortin receptors, with particular interest in MC3R and MC4R signaling.

Because melanocortin receptors participate in several biological signaling pathways, PT-141 has been studied in research involving receptor pharmacology, neurobiology, molecular signaling, and peptide-receptor interactions.

PT-141 research should be distinguished from the use of an approved pharmaceutical formulation. The material described on this page is presented specifically as a research compound.

PT-141 and Melanocortin Receptor Research

Melanocortin receptors are a family of G-protein-coupled receptors involved in multiple biological signaling processes.

PT-141 research has focused particularly on melanocortin receptor activity and the mechanisms through which peptide ligands interact with these receptors.

Research areas may include:

• MC3R receptor research
• MC4R receptor research
• Melanocortin signaling
• Peptide-receptor interactions
• Molecular pharmacology
• Neurobiology
• Peptide chemistry
• Receptor binding studies
• Structure-function research
• Analytical characterization

Research findings should be interpreted according to the experimental model and available scientific evidence.

PT-141 30mg Research Applications

Peptide Chemistry

Researchers may investigate the molecular structure, chemical characteristics, and analytical properties of PT-141.

Melanocortin Receptor Biology

PT-141 provides a research material for laboratory investigations involving melanocortin receptor systems, particularly MC3R and MC4R.

Molecular Signaling

Researchers may examine downstream signaling mechanisms associated with melanocortin receptor activation.

Neurobiology Research

Because melanocortin receptors are expressed in the central nervous system, PT-141 has been investigated in experimental neurobiology and signaling research.

Analytical Research

Laboratories may evaluate peptide identity, purity, stability, concentration, and other measurable characteristics using appropriate analytical methods.

PT-141 Liquid Spray Research Format

PT-141 30mg Research Spray is supplied in a liquid spray format rather than as a conventional lyophilized powder.

For laboratory research, a liquid peptide formulation may be evaluated for:

• Peptide concentration
• Formulation consistency
• Chemical stability
• Component identity
• Storage stability
• Spray-delivery characteristics
• Batch consistency
• Analytical properties

Researchers should follow the product-specific documentation for storage and handling requirements.

PT-141 30mg Certificate of Analysis

A Certificate of Analysis (COA) can provide useful batch-specific information when evaluating research peptide formulations.

Depending on the applicable batch, documentation may include:

• Product identification
• Batch or lot number
• Analytical testing
• Reported purity
• Concentration information
• Testing date
• Applicable specifications
• Laboratory test results

Researchers should review documentation associated with the specific batch being evaluated rather than relying exclusively on general product information.

Research Peptide Quality Considerations

When evaluating PT-141 30mg Research Spray, laboratories may consider:

• Compound identity
• Batch traceability
• Analytical documentation
• Reported purity
• Concentration
• Formulation characteristics
• Packaging
• Storage requirements
• Testing information
• Applicable regulatory requirements

PeptidesChemSupplier.com provides structured research-product information to help qualified laboratories evaluate peptide materials according to their scientific and analytical requirements.

PT-141 Research Peptide Supplier

Researchers searching for PT-141 research materials may use several different terms, including PT-141 30mg research spray, PT-141 research peptide, PT-141 research compound, bremelanotide research peptide, bremelanotide research material, and melanocortin receptor research peptide.

Including both PT-141 and bremelanotide terminology can make scientific product information easier for researchers to locate and identify.

International PT-141 Research

Researchers in different regions may use location-specific search terms when looking for research peptide materials.

Relevant searches can include:

• PT-141 30mg research spray USA
• PT-141 research peptide USA
• Bremelanotide research peptide USA
• PT-141 research spray UK
• PT-141 research peptide UK
• Bremelanotide research peptide UK
• PT-141 research spray Canada
• PT-141 research peptide Canada
• Bremelanotide research peptide Canada
• PT-141 research spray Europe
• PT-141 research peptide Europe
• Bremelanotide research peptide Europe
• PT-141 research spray Australia
• PT-141 research peptide Australia
• Bremelanotide research peptide Australia
• PT-141 research spray India
• PT-141 research peptide India

Availability, import requirements, customs rules, and regulatory requirements can differ between jurisdictions. Customers and laboratories are responsible for determining the requirements applicable to research materials in their location.

Geographic terminology is included to help researchers locate relevant information and does not imply authorization for human use in any particular country.

PT-141 and Scientific Research

PT-141 has been investigated in laboratory and clinical research contexts. Earlier studies examined its pharmacological activity and interaction with melanocortin receptors, while subsequent research evaluated different formulations and administration methods.

Scientific literature has also investigated the role of melanocortin signaling in neurobiology and related biological pathways. These studies provide scientific context for PT-141 but should not be interpreted as instructions for using a research product.

Frequently Asked Questions About PT-141 30mg

What is PT-141 30mg?

PT-141 30mg is a research-oriented peptide formulation associated with PT-141, also known as bremelanotide, and intended for qualified laboratory and analytical research.

What is PT-141 also called?

PT-141 is also known as bremelanotide. It is a synthetic peptide analogue related to α-MSH.

What receptors are associated with PT-141 research?

PT-141 has been investigated for activity at melanocortin receptors, including MC3R and MC4R.

Is PT-141 30mg intended for human use?

No. The product is presented strictly as research material and is not intended for human consumption, self-administration, or therapeutic use.

What research areas are associated with PT-141?

Research may include melanocortin receptor biology, molecular signaling, neurobiology, peptide chemistry, receptor-ligand interactions, analytical characterization, and formulation research.

Does PT-141 30mg have a COA?

Batch-specific analytical documentation may be available. Researchers should review the Certificate of Analysis associated with the specific batch being evaluated.

How should PT-141 30mg Research Spray be stored?

Storage and handling should follow the product-specific documentation supplied with the material and the procedures established by the relevant laboratory.

Research Use Disclaimer

PT-141 30mg Research Spray is supplied strictly for research, analytical, educational, and laboratory purposes.

It is not intended for human consumption, self-administration, medical use, therapeutic use, diagnostic use, veterinary use, or use as a food additive.

The information presented on this page is provided for scientific and educational purposes and should not be interpreted as medical advice or as a claim that PT-141 or bremelanotide can diagnose, treat, cure, or prevent any disease or medical condition.

Researchers, institutions, and purchasers are responsible for complying with applicable laws, regulations, import requirements, institutional policies, and laboratory safety requirements governing research materials in their jurisdiction.

Product composition, specifications, analytical information, availability, and documentation may vary by batch. Researchers should refer to the applicable product documentation and Certificate of Analysis for the specific material being evaluated.